Varnum
Brian Varnum, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20090214559 | Therapeutic Human Anti-IL-1R1 Monoclonal Antibody - Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described. | 08-27-2009 |
20120269824 | THERAPEUTIC HUMAN ANTI-IL-1R1 MONOCLONAL ANTIBODY - Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described. | 10-25-2012 |
20140039164 | THERAPEUTIC HUMAN ANTI-IL-1R1 MONOCLONAL ANTIBODY - Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described. | 02-06-2014 |
20140335099 | THERAPEUTIC HUMAN ANTI-IL-1R1 MONOCLONAL ANTIBODY - Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described. | 11-13-2014 |
Brian C. Varnum, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20140314691 | COMPOSITIONS FOR IMPROVING THE APPEARANCE AND/OR HEALTH OF TEETH - In various embodiments compositions are provided for the whitening, and/or brightening, and/or restoration of a tooth. In various embodiments the compositions, referred to herein as “dental care” compositions typically comprise a binding moiety that binds to calcium and/or to tooth enamel and/or to pellicle attached to an active agent. The active agent is selected to deliver a particular activity (e.g., whitening, remineralization, desensitization, brightening, etc.) to the tooth. | 10-23-2014 |
20160031941 | TARGETING PEPTIDES THAT BIND S. MUTANS, CONSTRUCTS COMPRISING SUCH PEPTIDES AND USES THEREOF - In certain embodiments, novel targeting peptides that specifically/preferentially bind to | 02-04-2016 |
Gerald G. Varnum, Pinckneyville, IL US
Patent application number | Description | Published |
---|---|---|
20160029926 | ORTHOPEDIC LOAD LIMIT WARNING APPARATUS - An orthopedic load limit warning apparatus having a pressure sensor shaped and sized for attachment to the underside of a user's lower appendage, the pressure sensor detecting and making a measurement of the load placed upon the sensor by the user, a pressure switch operatively associated with the pressure sensor, the pressure sensor communicating the load measurement to the pressure switch, and a sensory alarm connected to the pressure switch, the pressure switch selectively activating the sensory alarm to produce a sensory warning, the pressure sensor activating the sensory alarm when the load exceeds a predetermined level. | 02-04-2016 |
Grant Varnum, Twinsburg, OH US
Patent application number | Description | Published |
---|---|---|
20140060337 | BEVERAGE PRESS - A beverage press is shown and described. The beverage press may include a lid, a liquid containing member having upper and lower portions, where the upper portion of the liquid containing member is selectively engaged with the lid. The beverage press may also include a press operatively secured with the lid and extending within the liquid containing portion, where the press is microwaveable, and a solid retaining member selectively engaged with the lower portion of the liquid containing member. | 03-06-2014 |
Jason Jay Varnum, Saint Petersburg, FL US
Patent application number | Description | Published |
---|---|---|
20120227712 | Vaporize fuel for gasoline engines - Vaporize, in its simplest form, is gasoline vapors used to fuel a gasoline powered engine. | 09-13-2012 |
Robert M. Varnum, Beaverton, OR US
Patent application number | Description | Published |
---|---|---|
20120260078 | APPARATUSES FOR CONFIGURING PROGRAMMABLE LOGIC DEVICES FROM BIOS PROM - An apparatus comprising programmable logic devices including a field programmable gate array (FPGA) is presented. In one embodiment, the apparatus also comprises a programmable read only memory (PROM) to store a firmware which includes at least a system boot code and a configuration code. The apparatus further includes a configuration agent to configure the FPGA by using the configuration code and to release the reset to the CPU after the FPGA is configured. In one embodiment, the configuration agent comprises a SPI-FPGA bridge (serial peripheral interface to FPGA configuration interface). In one embodiment, the configuration agent is operable to determine whether the FPGA is ready for configuration based at least on a status from the FPGA. | 10-11-2012 |
Steve Varnum, Tigard, OR US
Patent application number | Description | Published |
---|---|---|
20090322291 | Integrated circuit with output drive power section - In some embodiments, one or more configurably or selectably engageable power transistors are integrated into a chip comprising an output drive power module for a voltage regulator (VR). In some embodiments, a chip with an output drive power module may have a pulse width modulator (PWM) input that can accommodate both a single PWM drive signal and independent high side and low side PWM drive signals. | 12-31-2009 |
Susan M. Varnum, West Richland, WA US
Patent application number | Description | Published |
---|---|---|
20130137595 | BIOMARKERS FOR LYMPHOMA - A biomarker, method, test kit, and diagnostic system for detecting the presence of lymphoma in a person are disclosed. The lymphoma may be Hodgkin's lymphoma or non-Hodgkin's lymphoma. The person may be a high-risk subject. In one embodiment, a plasma sample from a person is obtained. The level of at least one protein listed in Table S3 in the plasma sample is measured. The level of at least one protein in the plasma sample is compared with the level in a normal or healthy subject. The lymphoma is diagnosed based upon the level of the at least one protein in the plasma sample in comparison to the normal or healthy level. | 05-30-2013 |